NEO earnings call for the period ending December 31, 2020.
News & Analysis: NeoGenomics, Inc.
NEO earnings call for the period ending September 30, 2020.
The oncology reference lab never stopped investing in near- and long-term opportunities. It expects that to pay off -- and soon.
NEO earnings call for the period ending June 30, 2020.
These pioneers will be winners however the pandemic plays out.
Near-term headwinds won’t damage the long-term prospects of these two companies.
Invitae wants to provide medical-grade genetic testing to the masses. Is the business ready for the first big test?
The company decided to pull the trigger on a combined offering of stock and debt to pad its balance sheet during uncertain times.
Despite experiencing a double-digit decline in test volumes, the cancer genetics lab hasn't furloughed employees. It has even retooled labs to process COVID-19 swab and blood tests.
NEO earnings call for the period ending March 31, 2020.